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S U M M A R Y
We report a case of dengue hemorrhagic fever (DHF) complicated by acute myocarditis and review the
literature. A 65-year-old woman experienced DHF due to dengue virus serotype 3, complicated with
acute myocarditis and acute pulmonary edema. Clinically this masqueraded as acute myocardial
infarction, with an electrocardiographically depressed ST segment in precordial leads and elevated
serum cardiac-speciﬁc troponin I level. Under supportive management, the patient recovered 3 days
later. A total of 18 pertinent articles involving 339 dengue-affected patients with cardiac complications
were found by PubMed search. Clinical manifestations of cardiac complications varied considerably,
from self-limiting tachy–brady arrhythmia to severe myocardial damage, leading to hypotension and
pulmonary edema. Although rare, a fatal outcome was reported in some cases of dengue with cardiac
complications. To avoid otherwise preventable morbidity and mortality, physicians should have a high
index of suspicion for cardiac complications in patients with dengue illness and should manage this
accordingly.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Dengue is one of the most important mosquito-borne viral
diseases in the world.1 Clinically, a non-speciﬁc afebrile illness, a
mild-form dengue hemorrhagic fever (DHF), and dengue shock
syndrome (DSS) are commonly encountered in dengue epidemics.
Of note, a variety of cardiac complications have been reported in
dengue-affected patients,2–8 which include atrioventricular con-
duction disorders,5 supraventricular arrhythmia,6 and myocardi-
tis.7,8 During a dengue outbreak in southern Taiwan in 2006,
among 107 patients with dengue illness admitted to Chang Gung
Memorial Hospital-Kaohsiung (CGMH-KS; a 2500-bed facility
serving as a primary care and tertiary medical center), one was
found to be complicated with acute myocarditis and acute
pulmonary edema. We report this case, review the literature,
and discuss the implications of cardiac complications in dengue
patients. A better understanding of cardiac complications will
potentially improve the treatment of dengue illness by avoiding
otherwise preventable morbidity and mortality in the affected
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A 65-year-old woman presented to the emergency department
of CGMH-KS because of a 3-day fever, malaise, and bleeding gums.
She did not have any systemic disease, nor did she have a family
history of cardiovascular disease. Upon arrival, her ear tempera-
ture was 39.8 8C, pulse rate (PR) 119/min, respiratory rate (RR) 20/
min, and blood pressure (BP) 150/80 mmHg; her body weight was
52 kg, and multiple petechiae were found on bilateral legs.
Laboratory data disclosed that her peripheral white cell count
was 10.7  109/l (normal range 3.9–10.6  109/l) with 61%
polymorphonuclear cells, hemoglobin 14.5 g/dl (normal range
12–15 g/dl), hematocrit 42.4% (normal range 35–45%), platelet
count 11.0  109/l (normal range 150–400  109/l), prothrombin
time 10.2 s (control, 10.6 s), activated partial thromboplastin time
(aPTT) 71.4 s (control, 30.2 s), aspartate aminotransferase (AST)
2016 U/l (normal value<40 U/l), alanine aminotransferase 947 U/l
(normal value <40 U/l), and albumin 2.3 g/dl (normal range 3.0–
4.5 g/dl). A chest radiograph disclosed normal lungs and a slightly
enlarged heart size with a cardiothoracic ratio (CTR) of 0.65
(normal value for adults <0.5).9 Clinical examination and history
taking did not reveal any signs and/or symptoms suggestive of
heart failure. A tentative diagnosis of DHF was made based on the
ﬁndings of fever, bleeding gums, and petechiae, thrombocytopeniases. Published by Elsevier Ltd. All rights reserved.
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plementationwith 0.9% normal saline infused at a rate of 2 ml/h/kg
was started. Twelve units of platelets (50 ml/per unit) were
transfused for thrombocytopenia, and 3 units of fresh frozen
plasma (125 ml/per unit) were infused daily for three successive
days for coagulopathy.
Despite a high fever (ear temperature 39.3 8C), the normal saline
infusion was reduced to a rate of 0.4 ml/h/kg 17 h after her arrival
because of stable vital signs (BP 121/63 mmHg; PR 80/min; RR 17/
min).Her condition remaineduneventful until day3whenher blood
pressure dropped abruptly to 78/51 mmHg, coupled with a PR of
119/min. After intravenous ﬂuid challenge with 800 ml normal
saline, her bloodpressurewas increased to 100/67mmHgwithPRof
88/min. An inotropic agent was not administered. Her urine output
was not recorded. Because of relative hypotension and persistent
fever (ear temperature 38 8C), cefazolin and gentamicin were
parenterally administered after blood sampling for culture.
The patient experienced sudden onset of chest pain and
shortness of breath 22 h after the emergence of hypotension. On
examination, she was conscious but febrile (ear temperature
38.1 8C),with aPRof98/minandaBPof134/95mmHg.Auscultation
revealed coarse rales throughout her chest. A follow-up chest
radiograph showed progressive cardiomegaly (CTR was 0.79),
perihilar haze, and congestion over bilateral lower lung ﬁelds,
suggestive of pulmonary edema. The total volume of intravenous
ﬂuid supplement and transfused blood components was estimated
to be 5000 ml thus far. Intravenous ﬂuid was immediately
discontinued. Laboratory data revealed that her peripheral white
cell countwas 16.8  109/l, hemoglobin 11.0 g/dl, hematocrit 32.3%,
platelet count 80 109/l, aPTT 39.6 s (control, 30.2 s), and albumin
2.0 g/dl, and she had a remarkably elevated serum cardiac-speciﬁc
troponin I of 7.23 ng/ml (normal value <0.4 ng/ml).11,12 An
electrocardiogram showed ST segment depression (>1 mm) in
precordial leads V3–V6. A diagnosis of acute myocardial injury was
made by a cardiologist based on electrocardiographic ﬁndings and
the high serum cardiac-speciﬁc troponin I level.12 Despite suspicion
of an acute myocardial infarction or viral myocarditis, a coronary
angiogram for differential diagnosis and to determine the need for
primary coronary angioplasty was deferred because of thrombocy-
topenia and coagulopathy with active bleeding. In addition to
oxygen supplement, albumin 25% and furosemide (40 mg) was
intravenously infusedforherpulmonaryedema.Anechocardiogram
performed the following day disclosed a suboptimal left ventricular
functionwithanejection fractionof62%andend-diastolicvolumeof
79 ml. She continued receiving intravenous albumin plus furose-
mide for a further 2 days. Defervescence occurred on day 5 and her
peripheral white cell count was 13.2 109/l, hematocrit 37.1%, and
platelet count 144  109/l.
The patient’s blood culture was negative for bacterial growth,
and a serological test was positive for dengue virus (DEN)-speciﬁc
immunoglobulin M antibody. A reverse transcriptase-polymerase
chain reaction was positive for dengue virus serotype 3 (DEN-3).
Clinically she felt much better and refused further coronary
angiographic investigations. Subsequent serum troponin I values
were not available. She was discharged from the hospital on day 7.
Two days later, follow-up laboratory data at the outpatient clinic
showed that her peripheral white cell count was 7.8  109/l, AST
61 U/l, and albumin 3.2 g/dl. Clinically, she did not have any signs
of heart failure when she was last seen on day 27 after the onset of
dengue illness.
3. Literature review
We searched the PubMed database for articles published
between January 1975 and August 2008 in the English-language
literature. Medical subject headings (MeSH) including dengue,myocarditis, pericarditis, arrhythmia, and myocardial were cross-
referenced in the search, which was supplemented with a
secondary manual search.
A total of 18 pertinent articles involving 339 patients were
found from the PubMed search.2–8,13–23 The information retrieved,
including DEN serotype, demographics, cardiac manifestations,
and clinical outcomes is summarized in Table 1.2–8,13,15,19–21,23
Where DEN serotype(s) was mentioned, DEN-2 and DEN-3 had
been identiﬁed.2–5 Differing clinical severities were found, result-
ing from a wide spectrum of cardiac manifestations, which
included self-limiting tachy–brady arrhythmia2,5,6,13,20 and myo-
cardial damage with decreased left ventricular ejection fraction,
leading to hypotension and pulmonary edema.3,4,7,8,15,19,21,23 Most
of the affected patients were supportively treated for symptomatic
relief;3,4,7,8,15,19,21,23 some patients with left ventricle failure
required parenteral inotropic agents (i.e., dopamine and/or
dobutamine) for their cardiogenic shock.3,4 Although rare, a fatal
outcome was reported in dengue-affected patients with cardiac
complications.19,23
4. Discussion
The incidence of cardiac complications in patients with dengue
illness varies greatly from one series to another. From India,
Agarwal et al. reported that only one of 206 patients subjected to
cardiovascular evaluation experienced cardiac symptoms;14 Wali
et al., reported that 70% of 17 patients with DHF/DSS who
underwent myocardial scintigraphic study suffered diffuse left
ventricular hypokinesis with a mean ejection fraction of 40%;4 and
Kabra et al., reported that 16.7% of 54 children with dengue illness
had a decreased left ventricular ejection fraction of<50%.7 A recent
report from Sri Lanka showed that 62.5% of 120 adults with dengue
fever (DF) had an abnormal electrocardiogram.3 These series
suggest that cardiac complications in patients with dengue illness
are not uncommon, and might have been under-diagnosed
because most of the cases with cardiac complications are clinically
mild and self-limited.2
The clinical manifestations of cardiac complications in dengue
illness vary considerably.2–8,13–23 At one end of the clinical
spectrum, patients are asymptomatic or have mild cardiac
symptoms despite relative bradycardia, transient atrioventricular
block, and/or ventricular arrhythmia.2,6,5,13,20 At the other severe
end, patients may experience acute pulmonary edema and/or
cardiogenic shock due to severe myocardial cell damage with left
ventricular failure.3,4,7,8,15,19,21,23 Myocarditis can masquerade as
acutemyocardial infarction.23,24 The diagnosis of acutemyocardial
infarction could be made based on a rise in biochemical markers of
myocardial necrosis (serum creatine kinase-MB and/or cardiac
troponin I), coupled with ischemic symptoms and/or electrocar-
diographically developed Q waves or ST segment elevation/
depression.25 When it comes to indicators of myocardial necrosis,
troponin I is more sensitive andmore speciﬁc than creatine kinase-
MB.12 As for the cardiac complication in this reported patient, the
differential diagnosis included acute myocardial infarction and
acute myocarditis; the former is characterized by a blockage of the
coronary arteries, while the latter has patent coronary arteries.26
The bleeding tendency in this patient posed a high risk for an
invasive procedure and thus precluded an angiographic study for
the differential diagnosis and for angioplasty in the case of
myocardial infarct. However, rapid clinical improvement after the
development of hypotension and acute pulmonary edema
unequivocally indicated that this was a case of myocarditis.26
Myocarditis is not uncommonly found in viral infections other than
dengue.26
With respect to volume replacement for DHF patients with a
>20% increase in hematocrit, the World Health Organization
Table 1
Summary of demographic details, cardiac manifestations, and outcomes in dengue-affected patients with cardiac manifestations reported in the English-language literature
Author(s), year of
publication [Ref.]
No.
patient(s)
Gender or sex
ratio/age
(years)a
Cardiac manifestationsb (n [%]) Dengue serotype Outcome
Present case 1 F/65 Myocarditis, LVEF <62% DEN-3 Survived
Lee et al., 2008 [23] 1 M/25 Myocarditis, pulmonary congestion
and hypotension
ND Died
Kularatne et al., 2007 [3] 75 M:F=25:50/
median 34
Tachy–brady arrhythmia (58 [77%]),
hypotension (17 [23%]), and LVEF
<55% (5 [6.7%])
DEN-3 infection in
three patients and
DEN-2 in one with
data available
All survived
Ravindral et al., 2007 [2] 61 ND/ND Tricuspid regurgitation (35 [57%]), left
ventricular dilatation (13 [21%]) and
dual chamber dilatation (10 [16%])
DEN-2 Not reported
Khongphatthanayothin
et al., 2007 [21]
30 DF, 36 DHF,
25 DSS
ND/mean 9.62.8
(patients with DF);
ND/mean 11.42.7
(patients with DHF);
ND/mean 10.33.1
(patients with DSS)
LVEF <50% in two (6.7%) patients with
DF, ﬁve (13.8%) with DHF and nine
(36%) with DSS
ND All survived
Lateef et al., 2007 [20] 50 M:F=39:11/mean
32.810.8
Relative bradycardia ND ND
Malavige et al., 2006 [19] 2 ND/ND Low LVEF, pulmonary edema,
hypotension and tachycardia
ND Died
Promphan et al., 2004 [8] 1 M/13 Hypotension with junctional rhythm
and bradycardia and LVEF <40%
ND Survived
Horta Veloso et al., 2003 [6] 1 M/61 Acute atrial ﬁbrillation ND Survived
Khongphatthanayothin
et al., 2003 [15]
24 M:F=13:11/mean
10.82.8
Mean LVEF 53.39.0% ND ND
Khongphatthallayothin
et al., 2000 [5]
1 M/7 Mobitz type I 2nd degree atrioventricular
block
ND Survived
1 F/7 Mobitz type I 2nd degree atrioventricular
block
DEN-2 Survived
Wali et al., 1998 [4] 17 M:F=12:5/mean 29.76 Mean LVEF, 41.695.04% with global
hypokinesia in 12 patients (70.59%) (detected
by radionuclide ventriculography) and
47.063.8% (detected by echocardiogram)
DEN-2 All survived
Kabra et al., 1998 [7] 9 ND/<12 LVEF <50% ND All survived
Chuah, 1987 [13] 1 M/31 Transient ventricular bigeminy ND Survived
M, male; F, female; ND, no data available; DEN, dengue serotype; DF, dengue fever; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; LVEF, left ventricular
ejection fraction.
a In the event of case series, age is either median or mean age of the dengue-affected patients with cardiac manifestations.
b One patient might have had more than one cardiac manifestation; ventricular ejection fraction was determined by echocardiogram unless stated otherwise.
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saline at 6 ml/h/kg for the initial 1–2 h, followed by 3–5 ml/h/kg,
which may be discontinued at 24 to 48 h depending on the
normalization of hematocrit, pulse rate, and blood pressure.10
Overhydration may lead to ﬂuid overload, resulting in respiratory
distress in patients with dengue.10 In the present case, despite
improvement in the serial hematocrit after ﬂuid therapy,
hypotension developed on the third day of treatment suggesting
that this resulted from cardiac dysfunction rather than insufﬁcient
intravenous ﬂuid replacement, thus indicating that the patient’s
pulmonary edema was cardiogenic due to impairment of left
ventricular function.27
Myocardial dysfunction has been reported to be more severe in
patients with DSS when compared to those with DF or non-shock
DHF.21 The pathophysiology of myocardial cell injury in dengue
illness is not yet fully understood. Myocardial involvement in
dengue may result either from direct DEN invasion of the cardiac
muscles or a cytokine-mediated immunological response, or
both.28,29 The upsurge in serum tumor necrosis factor-a, inter-
leukins 6, 13 and 18, and cytotoxic factors in patients with dengue
illness lead to increased vascular permeability and shock;30,31
whether these cytokines play a role in the development of
myocardial cell injury is unknown. Of note, only DEN-2 and DEN-3
were reported to be the culprit viruses in dengue patients with
cardiac complications where the DEN serotype was mentioned.2–5
Further studies are needed to clarify the role that DEN serotype
plays, if any, in cardiac complications in dengue-affected patients.Our review shows that cardiac complications are not uncom-
mon in dengue illness. Although it was self-limiting in our patient
under supportive treatment, acute myocarditis in dengue may be
clinically severe to such an extent that it has a fatal outcome.19,23
Early recognition of myocardial involvement in dengue illness,
prompt restoration of hemodynamic instability while avoiding
ﬂuid overload, and sparing unnecessary invasive management are
important in treating dengue-affected patients with severe
myocarditis.
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